[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Inhalation Sedatives Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: IBB7C15BEC11EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Inhalation Sedatives in Global, including the following market information:

Global Inhalation Sedatives Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Inhalation Sedatives market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inhalation Sedatives companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inhalation Sedatives Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Inhalation Sedatives Market Segment Percentages, By Type, 2020 (%)
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
China Inhalation Sedatives Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Inhalation Sedatives Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Global Inhalation Sedatives Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Inhalation Sedatives Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Inhalation Sedatives Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Inhalation Sedatives Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • AbbVie Inc
  • Baxter International Inc
  • Novatis(Sandoz)
  • Fresenius
  • Halocarbon
  • Hikma Pharmaceuticals PLC
  • Piramal Enterprises Ltd
  • Troikaa Pharmaceuticals Ltd
  • Jiangsu Hengrui Medicine Co.,Ltd
  • Lunan Pharmaceutical Group Co.,Ltd
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Myxoid Round Cell Liposarcoma Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Myxoid Round Cell Liposarcoma Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MYXOID ROUND CELL LIPOSARCOMA DRUG OVERALL MARKET SIZE

2.1 Global Myxoid Round Cell Liposarcoma Drug Market Size: 2021 VS 2027
2.2 Global Myxoid Round Cell Liposarcoma Drug Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Myxoid Round Cell Liposarcoma Drug Players in Global Market
3.2 Top Global Myxoid Round Cell Liposarcoma Drug Companies Ranked by Revenue
3.3 Global Myxoid Round Cell Liposarcoma Drug Revenue by Companies
3.4 Top 3 and Top 5 Myxoid Round Cell Liposarcoma Drug Companies in Global Market, by Revenue in 2020
3.5 Global Companies Myxoid Round Cell Liposarcoma Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Myxoid Round Cell Liposarcoma Drug Players in Global Market
  3.6.1 List of Global Tier 1 Myxoid Round Cell Liposarcoma Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Myxoid Round Cell Liposarcoma Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Myxoid Round Cell Liposarcoma Drug Market Size Markets, 2021 & 2027
  4.1.2 Trabectedin
  4.1.3 Mechlorethamine
  4.1.4 Others
4.2 By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue & Forecasts
  4.2.1 By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2016-2021
  4.2.2 By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2022-2027
  4.2.3 By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Myxoid Round Cell Liposarcoma Drug Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Homecare
  5.1.4 Specialty Clinics
  5.1.5 Others
5.2 By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue & Forecasts
  5.2.1 By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2016-2021
  5.2.2 By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2022-2027
  5.2.3 By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Myxoid Round Cell Liposarcoma Drug Market Size, 2021 & 2027
6.2 By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue & Forecasts
  6.2.1 By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2016-2021
  6.2.2 By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2022-2027
  6.2.3 By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Myxoid Round Cell Liposarcoma Drug Revenue, 2016-2027
  6.3.2 US Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.3.3 Canada Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.3.4 Mexico Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Myxoid Round Cell Liposarcoma Drug Revenue, 2016-2027
  6.4.2 Germany Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.4.3 France Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.4.4 U.K. Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.4.5 Italy Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.4.6 Russia Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.4.7 Nordic Countries Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.4.8 Benelux Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Myxoid Round Cell Liposarcoma Drug Revenue, 2016-2027
  6.5.2 China Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.5.3 Japan Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.5.4 South Korea Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.5.5 Southeast Asia Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.5.6 India Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Myxoid Round Cell Liposarcoma Drug Revenue, 2016-2027
  6.6.2 Brazil Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.6.3 Argentina Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Myxoid Round Cell Liposarcoma Drug Revenue, 2016-2027
  6.7.2 Turkey Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.7.3 Israel Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.7.4 Saudi Arabia Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027
  6.7.5 UAE Myxoid Round Cell Liposarcoma Drug Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.1.4 Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.1.5 Johnson & Johnson Key News
7.2 Adaptimmune
  7.2.1 Adaptimmune Corporate Summary
  7.2.2 Adaptimmune Business Overview
  7.2.3 Adaptimmune Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.2.4 Adaptimmune Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.2.5 Adaptimmune Key News
7.3 GlaxoSmithKline plc
  7.3.1 GlaxoSmithKline plc Corporate Summary
  7.3.2 GlaxoSmithKline plc Business Overview
  7.3.3 GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.3.4 GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.3.5 GlaxoSmithKline plc Key News
7.4 Merck & Co., Inc
  7.4.1 Merck & Co., Inc Corporate Summary
  7.4.2 Merck & Co., Inc Business Overview
  7.4.3 Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.4.4 Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.4.5 Merck & Co., Inc Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.5.4 Novartis Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.5.5 Novartis Key News
7.6 Infinity Pharmaceuticals, Inc
  7.6.1 Infinity Pharmaceuticals, Inc Corporate Summary
  7.6.2 Infinity Pharmaceuticals, Inc Business Overview
  7.6.3 Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.6.4 Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.6.5 Infinity Pharmaceuticals, Inc Key News
7.7 Mirati Therapeutics,Inc
  7.7.1 Mirati Therapeutics,Inc Corporate Summary
  7.7.2 Mirati Therapeutics,Inc Business Overview
  7.7.3 Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.4.4 Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.7.5 Mirati Therapeutics,Inc Key News
7.8 Eli Lilly
  7.8.1 Eli Lilly Corporate Summary
  7.8.2 Eli Lilly Business Overview
  7.8.3 Eli Lilly Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.8.4 Eli Lilly Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.8.5 Eli Lilly Key News
7.9 Recordati SpA
  7.9.1 Recordati SpA Corporate Summary
  7.9.2 Recordati SpA Business Overview
  7.9.3 Recordati SpA Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.9.4 Recordati SpA Myxoid Round Cell Liposarcoma Drug Revenue in Global (2016-2021)
  7.9.5 Recordati SpA Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Inhalation Sedatives Market Opportunities & Trends in Global Market
Table 2. Inhalation Sedatives Market Drivers in Global Market
Table 3. Inhalation Sedatives Market Restraints in Global Market
Table 4. Key Players of Inhalation Sedatives in Global Market
Table 5. Top Inhalation Sedatives Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Inhalation Sedatives Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Inhalation Sedatives Revenue Share by Companies, 2016-2021
Table 8. Global Companies Inhalation Sedatives Product Type
Table 9. List of Global Tier 1 Inhalation Sedatives Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inhalation Sedatives Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Inhalation Sedatives Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Inhalation Sedatives Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Inhalation Sedatives Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Inhalation Sedatives Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Inhalation Sedatives Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Inhalation Sedatives Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Inhalation Sedatives Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Inhalation Sedatives Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Inhalation Sedatives Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Inhalation Sedatives Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Inhalation Sedatives Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Inhalation Sedatives Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Inhalation Sedatives Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Inhalation Sedatives Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Inhalation Sedatives Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Inhalation Sedatives Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Inhalation Sedatives Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Inhalation Sedatives Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Inhalation Sedatives Revenue, (US$, Mn), 2022-2027
Table 30. AbbVie Inc Corporate Summary
Table 31. AbbVie Inc Inhalation Sedatives Product Offerings
Table 32. AbbVie Inc Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 33. Baxter International Inc Corporate Summary
Table 34. Baxter International Inc Inhalation Sedatives Product Offerings
Table 35. Baxter International Inc Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 36. Novatis(Sandoz) Corporate Summary
Table 37. Novatis(Sandoz) Inhalation Sedatives Product Offerings
Table 38. Novatis(Sandoz) Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 39. Fresenius Corporate Summary
Table 40. Fresenius Inhalation Sedatives Product Offerings
Table 41. Fresenius Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 42. Halocarbon Corporate Summary
Table 43. Halocarbon Inhalation Sedatives Product Offerings
Table 44. Halocarbon Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 45. Hikma Pharmaceuticals PLC Corporate Summary
Table 46. Hikma Pharmaceuticals PLC Inhalation Sedatives Product Offerings
Table 47. Hikma Pharmaceuticals PLC Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 48. Piramal Enterprises Ltd Corporate Summary
Table 49. Piramal Enterprises Ltd Inhalation Sedatives Product Offerings
Table 50. Piramal Enterprises Ltd Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 51. Troikaa Pharmaceuticals Ltd Corporate Summary
Table 52. Troikaa Pharmaceuticals Ltd Inhalation Sedatives Product Offerings
Table 53. Troikaa Pharmaceuticals Ltd Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 54. Jiangsu Hengrui Medicine Co.,Ltd Corporate Summary
Table 55. Jiangsu Hengrui Medicine Co.,Ltd Inhalation Sedatives Product Offerings
Table 56. Jiangsu Hengrui Medicine Co.,Ltd Inhalation Sedatives Revenue (US$, Mn), (2016-2021)
Table 57. Lunan Pharmaceutical Group Co.,Ltd Corporate Summary
Table 58. Lunan Pharmaceutical Group Co.,Ltd Inhalation Sedatives Product Offerings
Table 59. Lunan Pharmaceutical Group Co.,Ltd Inhalation Sedatives Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Inhalation Sedatives Segment by Type
Figure 2. Inhalation Sedatives Segment by Application
Figure 3. Global Inhalation Sedatives Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Inhalation Sedatives Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Inhalation Sedatives Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inhalation Sedatives Revenue in 2020
Figure 8. By Type - Global Inhalation Sedatives Revenue Market Share, 2016-2027
Figure 9. By Application - Global Inhalation Sedatives Revenue Market Share, 2016-2027
Figure 10. By Region - Global Inhalation Sedatives Revenue Market Share, 2016-2027
Figure 11. By Country - North America Inhalation Sedatives Revenue Market Share, 2016-2027
Figure 12. US Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Inhalation Sedatives Revenue Market Share, 2016-2027
Figure 16. Germany Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 17. France Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Inhalation Sedatives Revenue Market Share, 2016-2027
Figure 24. China Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 28. India Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Inhalation Sedatives Revenue Market Share, 2016-2027
Figure 30. Brazil Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Inhalation Sedatives Revenue Market Share, 2016-2027
Figure 33. Turkey Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Inhalation Sedatives Revenue, (US$, Mn), 2016-2027
Figure 37. AbbVie Inc Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Baxter International Inc Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novatis(Sandoz) Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Fresenius Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Halocarbon Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Hikma Pharmaceuticals PLC Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Piramal Enterprises Ltd Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Troikaa Pharmaceuticals Ltd Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Jiangsu Hengrui Medicine Co.,Ltd Inhalation Sedatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications